Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00560638
Recruitment Status : Completed
First Posted : November 20, 2007
Last Update Posted : July 18, 2011
Information provided by:
Bausch & Lomb Incorporated

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2006
  Actual Study Completion Date : February 2006